Simplified Chinese
Batch Release Status of the Company’s Products in 2023
Release date:
2023-01-29
Author:
Source:
Abstract
The batch release status of the company’s products in 2023 is as follows:
The company's product 2023 annual batch issuance situation is as follows:
|
Serial number Serial No. |
Product Name Product Name |
Batch Batch |
|
1 |
acellular diphtheria–tetanus–pertussis and Haemophilus influenzae type b combination vaccine Diphtheria, Tetanus, Acellular Pertussis and Haemophilus influenzae type b combined vaccine |
23 batches 23 batch |
|
2 |
23-valent pneumococcal polysaccharide vaccine 23-valent pneumococcal polysaccharide vaccine |
12 batches 12 batch |
|
3 |
13-valent pneumococcal polysaccharide conjugate vaccine (tetanus toxoid/diphtheria toxoid) 13- valent pneumococcal polysaccharide conjugate vaccine(TT/DT) |
15 batches 15 batch |
|
4 |
Adsorbed Diphtheria–Tetanus–Pertussis Combined Vaccine Diphtheria, Tetanus and Acellular Pertussis combined vaccine, Adsorbed |
11 batches 11 batch |
| 5 |
Lyophilized Haemophilus influenzae type b conjugate vaccine
Haemophilus Influenzae Type b Conjugate Vaccine, Freeze-dried
|
4 batches
4 batch
|
| 6 |
Lyophilized Human Rabies Vaccine (Human Diploid Cell Line) Rabies Vaccine (Human Diploid Cell) for Human Use, Freeze - dried |
1 batch
1 batch
|
Batch Release Public Notice: https://bio.nifdc.org.cn/pqf/search.do?formAction=pqfGs
Batch release announcement: https://bio.nifdc.org.cn/pqf/search.do?formAction=pqfGs
Recommended Reading
Batch Release Status of the Company’s Products in 2026
2026-07-23
2026-07-15
2026-07-09